Qiagen Nv (QIA)

Index:

Xetra DAX

  41.33
   
  • Change Today:
     0.21
  • 52 Week High:  46.43
  • 52 Week Low:  28.12
  • Currency: Euro
  • Shares Issued: 130.00m
  • Volume: 116,503
  • Market Cap:  5,372m
Select chart: 1 week | 3 month | 1 year
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 2,134.89 589.11 219.33¢ 21.0 1.8 +12% 16.32¢ 0.0%
31-Dec-27 2,241.75 639.71 235.67¢ 19.6 2.6 +7% 25.89¢ 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
31-Dec-26 $16.42 2.50
31-Dec-27 $17.24 2.38

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
31-Dec-2026 2,135 2,135 n/a 2,140 n/a 2,200
31-Dec-2027 2,242 2,242 n/a 2,250 n/a 2,346
 
Earnings
31-Dec-2026 219.33¢ 220.10¢ n/a 212.66¢ n/a 219.47¢
31-Dec-2027 235.67¢ 236.57¢ n/a 229.77¢ n/a 239.37¢
 
Dividend
31-Dec-2026 16.32¢ 16.38¢ n/a 18.42¢ n/a 5.16¢
31-Dec-2027 25.89¢ 25.98¢ n/a 28.07¢ n/a 11.43¢
 
Recommendations
Strong Buy 5 5 0 5 0 0
Buy 4 3 0 3 0 0
Neutral 8 9 0 8 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 17 17 0 16 0 0
 
Average Rec 7.06 6.91 n/a 7.03 n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

Qiagen Nv Market Data

Currency Euro
Share Price   41.33
Change Today   0.21
% Change 0.50 %
52 Week High  46.43
52 Week Low  28.12
Volume 116,503
Shares Issued 130.00m
Market Cap  5,372m

What The Brokers Say

Strong Buy 5
Buy 4
Neutral 8
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page